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Abstract. The study was made on healthy common breed dogs on which, under general 
anesthesia, bone defects were made. For treatment were used scaffolds with hydroxyapatite-collagen 
support loaded with mesenchymal stem cells or the bone hole was covered with autologus periosteal 
flap. Evaluation of the healing process was made by clinical and, x-Ray exam. In guiding osseous 
regeneration in dog autologous periosteum has similar capacity, even better than autologous 
mesenchymal stem cells loaded on collagen impregnated with hydroxyapatite scaffolds. 
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INTRODUCTION 
 
Tisular engineering catalogues among possible therapeutically methods for the bone 
defects repair the usage scaffolds implants loaded with stem cells. 
The purpose of this study is to compare capacity of dog autologous periosteum and 
autologous mesenchymal stem cells in guiding osseous regeneration.  
 
MATERIAL AND METHODS 
 
Biologic material: 10 mixed breed weighing approximately 18 kg and 2-3 years old. 
After clinical examination and baseline laboratory tests all dogs were considered healthy. 
Before surgery, control X-ray exams of femoral region were carried out to exclude the 
eventually pathology at the places prepared for orthopedic intervention. 
Obtaining the scaffolds loaded with mesenchymal stem cells   
Under general anesthesia performed using premedication with acepromazine - 
ketamine and for maintenance isoflurane in oxygen, from 5 individuals (experimental group 
B), after the aseptic preparation of the region, bone marrow was aspirated by proximal 
humeral epiphyseal puncture. The samples were processed to obtain mesenchymal stem cells 
(MSCs), following a standard protocol and using as support for growing-loading-transplant 
collagen impregnated with hydroxyapatite scaffolds (Igna et al., 2008). 
Experimental protocol 
Under general anesthesia (N-NLA) with inhalatory narcosis (isoflurane), muscle 
relaxants and controlled ventilation, following a classical approach (Bojrab, 1983), in all ten 
dogs, in both pelvic legs, large diaphiseal defects were created as 2 cm2 holes (1 cm/2 cm) on 
the lateral aspect of the femur. The operation was performed under strict aseptic condition. 
For experimental group A (n=5), the defect achievement on the right limb was 
preceded by the elevation of a “U” shape periosteal flap (with a small sharp periosteal 
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elevator) which served afterwards as cover for the defect site and was fixed by simple 
interrupted sutures with absorbable material (Fig. 1). 
The defects from the left limbs of group B (n=5) were filled with hydroxyapatite 
scaffolds loaded with autologous MSCs (Fig. 2). In all dogs, osseous defects created in the 
opposite limb were left empty and were considered control (group C, n=10). Routine wound 
closure was performed in all cases. 
The evaluation of bone defects healing process was made through daily clinical exam 
for a period of 14 days and at 21 day and by repeated X-rays exam, in craniocaudal and 
mediolateral view of interested area, immediately after surgery (Fig. 3a, b) and in the 
postoperatory period at 7, 14, 21, and 28 days. Clinical examination includes inspection of the 
operatory wound, pain sensibility at palpation, general clinical status and presence/absence of 
lameness. For assessing functional disorders when the animal is walking a five levels scale 
was used: 0 = normal attitude in station and in walking – without lameness, 1 = in walking 
difficulties, especially at rapid carriage – fine lameness; 2 = in walking difficulties, 
intermittent lameness in rapid walking; 3 = evident lameness at every step, pain, 4 = the leg 
pull out of support in station and in walking, intense pain.  
 
  
Fig. 1a Defect site and periosteal flap Fig. 1b Sutured periosteal flap – group A 
 
Fig. 2 Hydroxyapatite scaffold loaded with MSCs fixed in the osseous defect – group B 
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RESULTS AND DISCUSSIONS 
 
At the clinical exam performed in booth experimental groups and in control group, 
during one week after the surgery all the subjects presented 2-3 degree of lameness. In daily 
exam performed in the next week, in standing position and with walking animal, it comes out 
that the lameness decreased in intensity, being discreetly and in accordance with the scale 
used for functional disorders assessing the first level. After 14 days, the functional disorders 
disappeared completely. In all the subjects the cutaneous incision healed uneventfully. Pain 
sensibility at the site of incision, lasts in the first postoperatory week, and disappeared 
completely at 14 days in subjects of experimental A and B group. In control group, the region 
exam by palpation showed an acute pain sensibility in first week which was diminished in 
intensity and completely disappeared at control made at 21 days.  
On radiographic exam, made at 7 days after surgery, it haven’t been observed 
differences between groups B and C regarding bone density changes in the area of the defect 
and around it, bone profile remained unaltered in craniocaudal view, the images being similar 
to those obtained immediate after surgery. On group A, radiological images from 
craniocaudal view showed at 7 days discreet changes of subperiosteal space with changes of 
bone defect contour. 
Preservation of periosteum is considered critical for limb bones fracture healing 
(Illizarov, 1989) and radiographic results of the study confirm these assumption. X-ray 
control made at 14 days on group A, revealed the presence of an inflammatory process that 
involves the periosteum around the defect, this process being extended even on the opposite 
site. In craniocaudal view was observed active osteogenesis, newly formed bone filling about 
50% of the bone defect. This new bone, immature bone tissue, also modifies the radiodensity 
of the defect in mediolateral view and has a lower density in comparison with the normal 
bone tissue surrounding the defect. The mineralization process has progressed at 21 days after 
surgery so that the new bone fills up totally the defect area and goes beyond that for few 
millimeters, bone defects covered with periosteum demonstrating slight elevation of their 
profile, aspects observed in oblique mediolateral view (Fig. 4). Ongoing of the healing 
process shown by X-ray images was similar at the whole group. The isolation of bone defects 
with periosteum reduce the involvement of adjacent tissues in the process of bone healing and 
allow bone marrow, a source of polypotent cells, to grow freely into the defect. Whereas one 
 
 
Fig. 3a Postoperatory craniocaudal view of defect site 
– group A 
Fig. 3b Postoperatory mediolateral view of defect site 
– group C  
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third or more of the diaphiseal blood supply comes from the periosteal vasculature 
(Rhinelander, 1968) in our study the periosteal flap was vascularized. All these elements are 
responsible for obvious tissue regeneration determined in this study. Our results correspond 
with those reported by Vögelin (2005) regarding healing of a critical-sized defect in the rat 
femur who showed that the addition of a vascularized periosteal flap significantly increased 
bone formation within the boundaries of the defect and prevented heterotopic ossification. The 
results of morphological, histopathological and scinthigraphical studies made on rabitts 
(Turgut, 2005) showed that periosteal flaps had a much faster and more stable reconstructive 
capacity of osteogenesis. 
 
  
Fig. 4a Group A, subject 1, craniocaudal view at 21 
days 
Fig. 4b Group A, subject 4, neutral mediolateral view 
at 21 days 
 
A large number of experimental studies showed that different scaffolds loaded or not 
with autologus mesenchymal stem cells are effective in promoting bone formation in various 
animal models such as sheep (Becker, 2006), dogs (Igna et al., 2002, 2008; Malard, 2005), 
rabbits (Dallari, 2006) and mice (Cancedda, 2003). Hydroxyapatite scaffolds loaded with 
autologous MSCs used in this study as bone replacement material, provides the same 
radiological outcomes as our previous studies made in dogs with tibial experimental defects 
(Dascalu et al., 2007; Igna et al., 2005, 2006, 2008). Radiographic images from the 
individuals of group B, obtained at 14 days are similar with those from the group A obtained 
at 21 and 28 days, demonstrating the osteogenesis capacity of scaffolds (Fig. 5). The 28 days 
control reveals a follow-up of new bone formation which exceeds even more the defect area 
and extends on the opposite site of this. Scaffolds fastening with the absorbable suture 
material determined a discontinuity of the newly formed bone. At 2 individuals from the 
group, the newly formed bone tissue proliferated proximal and distal to the defect and has 
extended on all length of the middle femoral diaphise. Unlike our results, Manjubala et all. 
(2005) observed that the ossification process of 4-mm holes on the lateral aspect of the femur 
filled with biphasic calcium phosphate ceramics, started after 4 weeks and the defect was 
completely filled with new woven bone after 12 weeks. This different result may be explained 
by the lack of scaffolds loading with MSCs which are considered to be involved in the 
osseous healing process.  
The porous scaffold structure allows controllable ingrowths of new bone tissue into 
the defect zone and enhancing of this process was achieved by loading the scaffolds’ structure 
with mesenchymal stem cells. The scaffold used in this study was easy to handle and fix into 
the defect zone, and finally resulted good performance regarding osseous defect healing. 
Results withdrawn from comparative analysis of radiographic images early made in 
postsurgery period, at 14 and 21 days, demonstrated that bone repair with periosteal flaps 
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does not lead to a faster rate of healing compared with scaffold loaded with MSCs, but rather 
to healing in the absence of exuberant bone formation. Moreover, a brief cost-benefit analysis 
indicates that application of periosteal flap to guided bone regeneration reduces total costs 
compared with those needed when scaffolds loaded with MSCs are used.  
 
 
 
Fig. 5 Group B, craniocaudal view at 21 days 
 
In group C, the X-ray exam performed in accordance with the same protocol reveals to 
all subjects the absence of osseous healing process at 7 and 14 days and his start at 21 days, 
put in evidence by the moderate differences of radio opacity and contour of the osseous defect 
in craniocaudal view in all subjects. On images obtained in booth views, on 60% of subjects it 
can be observed around the defect an inflammatory periosteal process, which is responsible 
for identified radiodensity modifications.   
Regeneration of bone defects represents a serious challenge in orthopedic surgery and 
today, promising approaches are available to solve this problem using scaffolds materials, 
different cell based strategies and the periosteum guiding capacity of osseous regeneration. 
The use of periosteal flap and hydroxyapatite scaffolds loaded with mesenchymal stem cells 
offers the surgeon the possibility to enhance osseous defects healing. Results documented in 
this study regarding the osteoconductive capacity of autologous periosteal flaps represents a 
promising, easy and real alternative method to improve the results of reconstructive 
orthopedic surgery. Further investigation must be made to establish the critical defect size in 
which the healing process conducted by periosteum remains efficient.  
 
CONCLUSIONS 
 
In osseous guided regeneration on dog, autologous periosteum has similar capacity 
with autologous mesenchymal stem cells loaded on hydroxyapatite scaffolds, the only 
difference being the exuberant proliferation of osseous tissue over cortical bone surface in the 
case of scaffolds.  
The healing process evolution on control group proves the reduced capacity of osseous 
tissue to heal the defect with large substratum loss without a specific treatment.  
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